alicaforsen IV (ISIS-2302)
/ Atlantic Healthcare, Ionis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 15, 2022
Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease
(clinicaltrials.gov)
- P3 | N=150 | Completed | Sponsor: Ionis Pharmaceuticals, Inc. | Unknown status ➔ Completed
Trial completion • Crohn's disease • Gastroenterology • Immunology • Inflammatory Bowel Disease • ICAM1
1 to 1
Of
1
Go to page
1